Our future journey in cystic fibrosis
Guided by our uncompromising commitment to patients, we are committed to going the distance in cystic fibrosis. Learn more about what we're focused on as we continue our journey.
Minimizing our environmental footprint
We’re committed to carefully managing our environmental footprint. Learn more from Charlie Wagner, our Chief Financial Officer, about the progress we’re making to conserve water and to reduce our greenhouse gas emissions.
Diana McKenzie
Diana McKenzie
Director
Audit and Finance Committee, Member
Management Development and Compensation Committee, Member
Ms. McKenzie joined our board in 2020. Ms. McKenzie was the Chief Information Officer of Workday, Inc., a cloud-based financial and human capital management software company, from February 2016 until April 2019. From 2004 through February 2016, she held roles of increasing responsibility at Amgen Inc., a biotechnology company, most recently serving as Senior Vice President and Chief Information Officer. Ms. McKenzie served for 17 years at Eli Lilly and Company, a pharmaceutical company, in various leadership roles, focused on drug development, reducing time to market and improving technology and security standards. She currently serves as a member on the board of directors of agilon health, inc., MetLife, Inc., and Paradox AI, and as a Special Advisor to Brighton Park Capital. Ms. McKenzie also served as a member on the board of directors of Change Healthcare, Inc., a publicly traded healthcare technology company from August 2019 until it was acquired by United Health Group in October 2022. Ms. McKenzie holds a Bachelor of Science degree in computer information systems from Purdue University and completed the Information Technology Management Program at University of California, Los Angeles, and the CERT Certification for Cybersecurity Oversight from Carnegie Mellon’s Software Engineering Institute.
Ms. McKenzie joined our board in 2020. Ms. McKenzie was the Chief Information Officer of Workday, Inc., a cloud-based financial and human capital management software company, from February 2016 until April 2019. From 2004 through February 2016, she held roles of increasing responsibility at Amgen Inc., a biotechnology company, most recently serving as Senior Vice President and Chief Information Officer. Ms. McKenzie served for 17 years at Eli Lilly and Company, a pharmaceutical company, in various leadership roles, focused on drug development, reducing time to market and improving technology and security standards. She currently serves as a member on the board of directors of agilon health, inc., MetLife, Inc., and Paradox AI, and as a Special Advisor to Brighton Park Capital. Ms. McKenzie also served as a member on the board of directors of Change Healthcare, Inc., a publicly traded healthcare technology company from August 2019 until it was acquired by United Health Group in October 2022. Ms. McKenzie holds a Bachelor of Science degree in computer information systems from Purdue University and completed the Information Technology Management Program at University of California, Los Angeles, and the CERT Certification for Cybersecurity Oversight from Carnegie Mellon’s Software Engineering Institute.